Researchers discover new class of drugs that inhibits a ‘master switch’ in mantle cell lymphoma

By | June 23, 2021
A new class of drugs that inhibits a “master switch” involved in the vast majority of cases of mantle cell lymphoma (MCL), a fatal subtype of non-Hodgkin’s lymphoma, has been discovered by researchers at Mount Sinai.